
The Role Of Technology In Transforming The Infrastructure That Moves Us Forward
America's infrastructure—the silent backbone of our daily lives—is undergoing a much-needed transformation. From the roads we drive on to the pipes that deliver our water, these interconnected systems are fundamental to our economy, global competitiveness and quality of life. We take them for granted when they're functioning seamlessly, but any inefficiency or failure is quickly felt by households and businesses.
After decades of underinvestment, this is not the time to let up on the gas. We need to sustain the momentum created by recent federal investments from the Infrastructure Investment and Jobs Act (IIJA). With technological advances bridging gaps and fueling progress, we should continue to modernize our vital infrastructure.
The Foundation Under Our Feet
Infrastructure encompasses much more than most realize. Beyond highways, streets, mass transit, ports, airports and inland waterways, it includes dams, levees, utility networks and public schools. These public and private networks provide the power, water, waste removal, recreation and education essential for daily life.
The latest Report Card for America's Infrastructure from the American Society of Civil Engineers (ASCE) is a 'C' overall (up slightly from a 'C-'), indicating recent federal investments from IIJA have led to improvements in several infrastructure sectors. But much work is still needed to meet future demands.
As our existing systems continue to age, demands steadily increase, leading to a substantial investment gap. For instance, 39% of major U.S. roads are in poor or mediocre condition, costing the average driver over $1,400 annually in vehicle operating costs and lost time, according to the infrastructure report card. Bridges also face an uphill battle, with 49.1% in "fair" condition, requiring attention to prevent costlier deterioration. Bridge rehabilitation needs in the U.S. still stand at $191 billion.
Prior to the IIJA, federal infrastructure spending was about 1.5% of GDP, relatively small compared to the United Kingdom (2%), France (2.4%) and Australia (3.5%), according to a 2021 Brookings Metropolitan Policy Program report. At 1.4%, Germany spends slightly less than the U.S. The IIJA, while significant, expires in 2026, leading to uncertainty about sustained funding.
Addressing The Infrastructure Construction Workforce Shortage
A growing workforce shortage in infrastructure construction also holds us back. Many experienced professionals are retiring or moving to the private sector, leaving state Departments of Transportation (DOTs) struggling and forced to do more with less.
The Federal Highway Administration's Every Day Counts (EDC) program helps address this by driving technology adoption in state and local transportation. EDC promotes innovations like e-construction and 3D models to reduce errors and rework, yielding efficiency gains and cost savings. Since EDC's inception in 2009, each state has used 26 or more of its 57 promoted innovations, with many now as mainstream practices.
Paving The Way With Connected Workflows
Infrastructure agencies and partners are increasingly embracing digital technologies and prioritizing data sharing and connected workflows across design, construction, asset management and maintenance departments. The Colorado Department of Transportation used innovative project delivery methods to replace its Region 2 Bridge Bundle project about five months ahead of schedule and $2 million under budget. Here are other examples:
• All-digital workflows use mobile mapping and lidar (light detection and ranging) for rapid and highly accurate data collection, significantly reducing the need for human presence in dangerous areas and enhancing safety. Some state DOTs stipulate that surveyors use mobile lidar in specific contexts for enhanced data collection, project accuracy and safety.
• Artificial intelligence (AI) processes vast amounts of lidar, location and image data for asset inventories and condition assessments. This means quicker, more precise identification of infrastructure needs, allowing for proactive maintenance rather than costly reactive repairs.
• Integrated workflows in machine control systems load 3D design models directly onto construction equipment, enabling high-accuracy operations guided by digital designs.
• Interoperability is also a crucial data advancement, fostering seamless data exchange between different software and systems used by various stakeholders. In fact, the most advanced states go a step further. By standardizing on a vendor and embracing integrated workflows, they are seeing increased cost savings and efficiencies. For instance, a Minnesota DOT project reduced a 600-hour process to 73 hours, an 87% efficiency increase.
Funding programs like the SMART Grants Program and the Advanced Digital Construction Management Systems (ADCMS) Grant Program actively support technological adoption. These grants incentivize DOTs to modernize workflows and embrace digital construction technologies, leading to significant cost savings. Recent permitting reforms are another indicator that the government is digitizing and leveraging technology to streamline and accelerate processes and reduce red tape.
This digital transformation extends beyond roads and bridges. Wastewater utilities use Geographic Information Systems (GIS) and advanced metering; the energy sector invests in smart grids and AI for capital allocation, peak identification, load forecasting and automated rerouting; and public parks utilize GIS and digital twin maps for asset management.
Business Leaders: Your Role In Shaping The Future Of Infrastructure
This technological revolution in infrastructure extends beyond government agencies. Leaders across construction, technology, government and related industries are crucial to achieving a world-class infrastructure system. Here's how you can contribute:
• Embrace new methods: Businesses across sectors can benefit from digital delivery, 3D scanning, AI and data analytics, optimizing internal operations and creating demand for advanced solutions.
• Advocate for sustained investment: Emphasize the long-term economic benefits of resilient, technologically advanced infrastructure, highlighting its direct impact on commerce and reduction of costly disruptions.
• Engage on policy: Stay informed and engaged in policymaking at all levels of government to ensure we are getting the most from our tax dollars. Communicate industry needs to representatives, supporting policies that incentivize innovation, promote interoperability and address workforce development in civil engineering and related fields.
By embracing technological innovation and advocating for smart, sustained investments, business and technology leaders can help ensure that America's infrastructure is not just maintained but transformed to support the demands and aspirations of the 21st century and beyond.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Purpose Investments Announces Termination of Three Investment Funds
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. ('Purpose Investments') announced today its decision to terminate StoneCastle Equity Growth Fund and StoneCastle Income Growth Fund (each, a 'StoneCastle Fund' and together, the 'StoneCastle Funds') at the close of business on or about September 29, 2025 (the 'StoneCastle Funds' Termination Date'). Effective immediately, each StoneCastle Fund is closed to new purchases. Purpose Investments also announced its decision to terminate PK Core Fund effective as of the close of business today. PK Core Fund currently has no unitholders and is closed to new purchases. StoneCastle Funds Purpose Investments regularly reviews its fund offerings to ensure each offering is appropriately scaled, cost-effective, and economically viable for investors, while continually enhancing our fund platform to better serve investors. As part of its latest review, a decision was made to terminate the StoneCastle Funds due to their relatively small size, which has made it challenging to manage the StoneCastle Funds efficiently in accordance with their stated investment objectives. Holders of Series A and Series F shares of either StoneCastle Fund (collectively, the 'Shares') will have the option to redeem their Shares at net asset value on or prior to September 24, 2025, at 4:00 p.m. (EDT). No fees or redemption charges will apply. All Shares not redeemed prior to 4:00 p.m. (EDT) on the Termination Date will be automatically redeemed at net asset value, with the proceeds either deposited into the shareholder's account or sent via cheque mailed directly to the shareholder, dealer, nominee, or intermediary, as applicable. If required, a final distribution for each StoneCastle Fund will occur on or about the StoneCastle Funds' Termination Date. Shareholders will be sent a written notice regarding the termination of the StoneCastle Funds. There may be tax implications for shareholders with respect to any disposition of Shares. Shareholders are strongly encouraged to contact their financial advisor to discuss the financial and tax implications associated with a redemption of Shares and the termination of the StoneCastle Funds. About Purpose Investments Purpose Investments is an asset management company with more than $25 billion in assets under management. Purpose Investments has an unrelenting focus on client-centric innovation and offers a range of managed and quantitative investment products. Purpose Investments is led by well-known entrepreneur Som Seif and is a division of Purpose Unlimited, an independent technology-driven financial services company. For further information, please contact info@ Media Inquiries: Keera Hart 905-580-1257 Commissions, trailing commissions, management fees and expenses all may be associated with investment fund investments. The prospectus contains important detailed information about the investment fund. Please read the prospectus before investing. There is no assurance that any fund will achieve its investment objective, and its net asset value, yield, and investment return will fluctuate from time to time with market conditions. Investment funds are not guaranteed, their values change frequently, and past performance may not be cautions the reader not to place undue reliance upon any such forward-looking statements contained herein, which speak only as of the date they are made. Generally, but not always, forward-looking information can be identified by the use of forward-looking terminology such as 'plans', 'expects' or 'does not expect', 'is expected', 'budget', 'scheduled', 'estimates', 'forecasts', 'intends', 'on pace', 'anticipates' or 'does not anticipate', 'believes' and similar expressions or statements that certain actions, events or results 'may', 'could', 'would', 'should', 'might' or 'will' be taken, occur or be achieved. Forward-looking statements are based on information available to management at the time they are made, management's current plans, estimates, assumptions, judgments and expectations. Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause the actual results, level of activity, performance or achievements of Purpose to be materially different from those expressed or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to: general business, economic, competitive, geopolitical, technological and social uncertainties. Although the forward-looking information contained in this press release is based on assumptions that Purpose believes to be reasonable at the date such statements are made, there can be no assurance that the forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. Purpose does not undertake to update or revise any forward-looking information, except in accordance with applicable securities in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
CoStar Group, Inc. (CSGP): A Bull Case Theory
We came across a bullish thesis on CoStar Group, Inc. on Andvari's Substack by Douglas Ott. In this article, we will summarize the bulls' thesis on CSGP. CoStar Group, Inc.'s share was trading at $92.96 as of July 24th. CSGP's trailing and forward P/E were 357.54 and 222.22 respectively according to Yahoo Finance. An elegant residential building set against the modern skyline. CoStar Group reported another quarter of strong performance in Q2 2025, marking its 57th consecutive quarter of double-digit revenue growth with sales up 15% year over year and all-time high net new bookings of $93 million. Adjusted EBITDA rose 108% to $85 million, and membership surged 56% sequentially. Despite a slight dip in gross margins from the February addition of Matterport, operational restructuring is underway, including eliminating unprofitable units and expanding its salesforce. remains the centerpiece of CoStar's strategy, with a dedicated and growing sales team driving subscription adoption, improved agent Net Promoter Scores rising from 4 to 38 over three quarters, and marketing investments stabilizing monthly active users. Regulatory and legal pressures on competitors create tailwinds: in the U.S., Zillow faces an antitrust lawsuit from Compass over restrictive listing practices, enabling CoStar to boost profile by offering free advertising to banned listings; and in Australia, REA Group, dominant in the market, faces an antitrust investigation amid steep agent fee hikes, coinciding with CoStar's planned acquisition of challenger portal Domain. Additional uncertainty arises from potential leadership reshuffling within REA and U.S.-based both owned by the Murdoch family, which could further benefit Domain. With targeting an expansion of its salesforce from 230 to 750 by year-end and a stabilizing user base, CoStar appears increasingly well-positioned to challenge entrenched incumbents like Zillow and REA. Supported by operational momentum, strategic acquisitions, and heightened competitive scrutiny, CoStar's residential portals hold growing potential to emerge as true category leaders rather than cash-intensive experiments. Previously we covered a on CoStar Group, Inc. (CSGP) by Douglas Ott in February 2025, which highlighted CoStar's aggressive expansion of its strong financial base, and potential for margin recovery as investments scale. The company's stock price has appreciated about 20% since our coverage. The thesis still stands as execution remains robust. Douglas Ott shares a similar view but emphasizes regulatory tailwinds and operational gains. CoStar Group, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 51 hedge fund portfolios held CSGP at the end of the first quarter which was 56 in the previous quarter. While we acknowledge the potential of CSGP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry
International Conference of the Modernization of Chinese Medicine & Health Products to be held next month to foster progress in traditional medicine research - The implementation of streamlined approval procedures for Hong Kong- and Macao-registered proprietary Chinese medicines ("pCms") by mainland China presents significant opportunities for Hong Kong companies to expand into the Greater Bay Area and other mainland market.- A unified and comprehensive registration system strengthens the quality control of Hong Kong's pCms, reinforcing confidence among other regulatory bodies and stakeholders.- Hong Kong's first Chinese medicine hospital will gradually commence operations by year end. This will help promote the popularity of Chinese medicine and pCms. HONG KONG - July 25, 2025 (NEWMEDIAWIRE) - The Hong Kong Trade Development Council ("HKTDC") today released a report, "Challenges and Opportunities in Hong Kong's Proprietary Chinese Medicine Industry," that analyses the sector's development, challenges, and export potential of Hong Kong's pCm sector. With the completion of the transitional registration process for pCms in June this year, all pCms sold in Hong Kong now hold formal registration, marking a new era in the regulatory regime. The Chinese Medicine Hospital of Hong Kong is set to begin operations by late 2025 further popularising pCms. Additionally, mainland China has streamlined approval procedures for Hong Kong-registered traditional pCms, creating easier access to the mainland market. Hong Kong's pCms enjoy a strong reputation, with streamlined registration procedures facilitating expansion into the Mainland market Hong Kong currently has approximately 2,000 companies involved in pCms and Chinese herbal medicine-related businesses, including import/export trade, manufacturing, wholesale and retail. Among these, some 264 enterprises are listed as local pCm manufacturers. The majority of pCms produced in Hong Kong are geared toward the consumer market. In 2024, Hong Kong's pCm exports totaled HK$2.88 billion with 93% locally produced, setting the industry apart from re-export-driven sectors. Mainland China remains the largest export market, accounting for over 70% of exports, followed by Macao (20%), and ASEAN (6%). Wing Chu, Principal Economist (Greater China) of the HKTDC, stated: "Many Hong Kong proprietary Chinese medicines companies are eager to expand exports especially to the mainland market although pCm imports in mainland China are relatively small, with different pCms registration system and technical standards from those of Hong Kong. Notably, Hong Kong's pCms are highly regarded in Southern China and overseas Chinese communities, and streamlined approval procedures in mainland China for traditional pCms of Hong Kong and Macao offer significant opportunities for Hong Kong businesses to expand into the Greater Bay Area and other mainland markets. Additionally, the rise of online shopping enables companies to leverage cross-border e-commerce platforms to access mainland and overseas markets, provided they comply with the corresponding regulatory requirements." Comprehensive registration system drives standardisation of Chinese medicine The report indicates that, in recent years, the HKSAR Government has actively promoted the development of Chinese medicine. Key initiatives include the establishment of the Chinese Medicine Council of Hong Kong to oversee the registration and management of pCms, and continuous support for Chinese medicine services in areas such as education, medical treatment, and scientific research. These efforts have enabled Hong Kong to cultivate professional Chinese medicine talent and promote the modernisation of Chinese medicine. Earlier this month, some 345 Hong Kong enterprises, including traders, registered a total of 8,244 pCms. The report states that a unified and comprehensive registration system enhances the quality control of Hong Kong's pCms, further increasing the confidence of other regulatory bodies and stakeholders in these products. Hong Kong's first Chinese medicine hospital is set to open in late 2025, providing comprehensive diagnostic and treatment services with Chinese medicine, which will drive the popularisation of Chinese medicine and pCms. In addition, Hong Kong pCm companies and local universities are committed to developing new pCms to further expand the market. Recently, the Centre for Chinese Herbal Medicine Drug Development at Hong Kong Baptist University (HKBU), funded by the Innovation and Technology Commission of HKSAR Government under the InnoHK Research Clusters, developed a novel drug, CDD-2101, for the treatment of chronic constipation. The innovation is based on previous pilot clinical studies and basic research on the traditional Chinese herbal formulation "MaZiRenWan". For the first time, it has received authorisation for clinical research in the United States. Prof. BIAN Zhaoxiang, Director of the Centre for Chinese Herbal Medicine Drug Development and Associate Vice-President (Clinical Chinese Medicine) at HKBU, said: "Our goal is to collect sufficient safety and efficacy data to obtain FDA approval for CDD-2101 as a marketable new drug and successfully launch it in the United States. This represents not only a major breakthrough in the research and development of Chinese medicine in Hong Kong but also an important step in driving the standardisation and internationalisation of Chinese medicine." Mainland market surpasses RMB450 billion Mainland China, the world's largest pCm market valued at RMB450 billion, streamlined registration and approval procedures in 2021 for traditional pCms for external use being sold in Hong Kong and Macao. In January 2025, the National Medical Products Administration further simplified the approval process for traditional pCms for oral use, provided they have been in use in Hong Kong for more than 15 years and whose production processes comply with Good Manufacturing Practice (GMP) requirements. Relevant application materials and technical requirements were also released in April this year. The report notes that the implementation of the streamlined registration procedures opens a more convenient channel for Hong Kong companies to expand into the Greater Bay Area and other mainland markets. The recognition and acceptance of pCms differ across overseas regions. In many international markets, pCms are categorised and regulated as herbal medicines, health foods or dietary supplements. However, many Southeast Asian countries have specific, similar legal requirements for pCms, providing a clear pathway to enter these markets. The rapid growth of global e-commerce has created new sales channels for Hong Kong's pCms through cross-border e-retail. For the mainland market, the report points out that certain pCms for external use, such as Chinese medicinal wines and cooling oils, have been incorporated in the Cross-border E-commerce Retail Import Commodity List, allowing relevant products to be sold to mainland China through cross-border e-commerce channels. In overseas markets, the e-commerce retail sector in ASEAN is experiencing significant growth, fueled by robust demand for herbal and health-related products in local markets. By adhering to local regulations, Hong Kong pCm enterprises can capitalise on additional business opportunities through online channels. Annual Chinese Medicine Conference to Share Latest Research Findings To foster the development of the Chinese medicine industry, the International Conference of the Modernization of Chinese Medicine & Health Products will be held at the Hong Kong Convention and Exhibition Centre from 15 to 16 August 2025. The conference is jointly organised by the Modernized Chinese Medicine International Association, the HKTDC and 10 scientific research institutions. During the event, 21 scholars and experts from medical schools, research institutions, pharmaceutical companies and organisations from mainland China, Hong Kong, Malaysia and Thailand will discuss the latest research progress in the prevention and treatment of tumors, inflammation, and cardiovascular and cerebrovascular diseases using traditional medicine. They will also present a number of related clinical research results and share successful cases. For more details, please visit: Report and photo download: Media Enquiries Ogilvy Public Relations Chole Chan Tel: (852) 6809 6633 Email: Leanne Pok Tel: (852) 9379 9694 Email: HKTDC's Communications and Public Affairs Department Stanley So Tel: (852) 2584 4049 Email: Serena Cheung Tel: (852) 2584 4272 Email: Clayton Lauw Tel: (852) 2584 4472 Email: Media Room: About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data